RE:CXRX Bought Drugs To Jack up PricesSome of this could soon be rectified. The health bill in the UK is going for its second reading early next week and if it passes it should be law by spring. The company has not allowed for any price caps/rollbacks in their numbers and any prcing pressure could drastically affect target prices due to the leverage. The company was one of the main targets in The Times investigation which exposed the price jacking and abuse of the loophole so I think they will be in the direct crosshairs of the bill.
GenericAdvocate wrote: Companies need to be held accountable for unethical pricing practices. Pharmaceuticals are not ordinary market commodities. Government will not allow the private sector to determine market dynames because there are access issues to patients. If you are in Canada, you do not appreciate this problem because of your health care system. But I guess that's why Concordia doesn't peddle their drugs in Canada since they can't price gouge there. Instead, Canadians just got fleeced into buying their stock.